Back to Search
Start Over
Mucin 5 AC (MUC5AC) to predict pathologic treatment response (TR) to neoadjuvant chemotherapy (NAT) in resected-pancreatic ductal adenocarcinoma (R-PDA).
- Source :
- Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p690-690, 117p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 42
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 174954785
- Full Text :
- https://doi.org/10.1200/JCO.2024.42.3_suppl.690